ArticleCancers2024

First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA).

Jean-Louis Legoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.